Literature DB >> 23319972

Antimicrobial susceptibility and genetic similarity of ESBL-positive Klebsiella pneumoniae strains.

Alicja Sękowska1, Eugenia Gospodarek, Dorota Kamińska.   

Abstract

INTRODUCTION: Twenty-eight isolates of extended-spectrum β-lactamase (ESBL)-positive Klebsiella pneumoniae were studied.
MATERIAL AND METHODS: The strains were cultured from different clinical specimens obtained from children hospitalised at the University Hospital in Bydgoszcz. Seventeen strains were isolated from colonization and eleven from clinical infection. Isolation and identification of bacteria were performed using routine methods at the clinical microbiology laboratory. Production of ESBL was assessed using the double disk synergy test. The susceptibility to imipenem and tigecycline was tested by the Etest. The susceptibility to gentamicin and ciprofloxacin was tested by the agar dilution method. The genomic DNA was extracted from the strains separated by pulsed-field gel electrophoresis (PFGE) after digesting with XbaI endonuclease.
RESULTS: Among analysed K. pneumoniae strains all were susceptible to imipenem, 21 (75.0%) were susceptible to tigecycline, 14 (50.0%) to gentamicin and 5 (17.9%) to ciprofloxacin. Molecular typing results revealed a great genetic diversity among K. pneumoniae isolates. All repeated PFGE patterns were detected in seven K. pneumoniae isolates. Among identical K. pneumoniae strains four susceptibility patterns were detected.
CONCLUSIONS: The results of the study suggest that establishing strains' similarity in epidemiological investigations should be based on results obtained by several methods, and that each phenotyping method should be complemented with genetic research.

Entities:  

Keywords:  ESBL phenotype; Klebsiella pneumoniae; pulsed-field gel electrophoresis; susceptibility to antibiotics

Year:  2012        PMID: 23319972      PMCID: PMC3542488          DOI: 10.5114/aoms.2012.32404

Source DB:  PubMed          Journal:  Arch Med Sci        ISSN: 1734-1922            Impact factor:   3.318


Introduction

Klebsiella pneumoniae rods are one of the most important bacteria which cause nosocomial infections, especially at paediatric units. β-Lactamases are the most frequent source of resistance to β-lactam antibiotics. Different β-lactamases are known: penicillinases, extended-spectrum β-lactamases (ESBL), cephalosporinases (AmpC), metallo-β-lactamases (MBL) and carbapenemases (KPC). Each of them can be produced by Klebsiella strains. Klebsiella pneumoniae are one of the most frequent ESBL producers, including in Poland [1-3]. Strains with this phenotype hydrolyse penicillins and some cephalosporins, and are normally not inhibited by β-lactamase inhibitors. ESBL-positive strains are often resistant to non-β-lactam antibiotics, so treatment of these infections appears to be very difficult because of the strains’ multidrug resistance. Since ESBL-producing strains were first recognized, their emergence and rapid dissemination have been responsible for numerous outbreaks of infection throughout the world [4-6]. Strains with this phenotype generally remain susceptible to only a few antimicrobial agents, some of which are not always recommended for use in children. Phenotypic methods such as biotyping and serotyping have been providing the mainstay in descriptive epidemiology of bacteria. Genetic methods allow one to evaluate the relatedness of strains and the epidemiological situation in a hospital. Pulsed-field gel electrophoresis (PFGE) is a genetic typing method that is widely used as a molecular epidemiological tool for studying the genetic diversity of K. pneumoniae [7, 8]. The purpose of this dissertation was to evaluate antimicrobial susceptibility and genetic similarity of ESBL-positive K. pneumoniae strains isolated from colonization and infections from children hospitalised at the Paediatric Surgery Unit at the Dr Jurasz University Hospital in Bydgoszcz in a period of 15 months.

Material and methods

The study included 28 K. pneumoniae strains isolated from 18 children. Isolation and identification of bacteria were performed using routine methods at the clinical microbiology laboratory. The isolates were identified with commercial ID32E tests (bioMérieux). The antimicrobial susceptibility tests for gentamicin and ciprofloxacin were performed by the agar dilution method. Minimal inhibitory concentration (MIC) for imipenem and tigecycline was determined by the Etest (AB Biodisk). Susceptibility breakpoints for antibiotics were established according to the recommendations of the European Committee on Antimicrobial Susceptibility Testing [9]. Escherichia coli ATCC 25922 and K. pneumoniae ATCC 700603 were used as reference strains. For every strain the ESBL producing ability was determined by means of two disks and the EUCAST method. Genetic relatedness was assessed by PFGE using XbaI enzyme. Electrophoresis conditions were as follows: 14°C at 6 V/cm for 20 h with pulse time ranging from 2 s to 35 s. As a reference chromosomal DNA pattern Lambda Ladder standard (Bio-Rad) was used. Results were interpreted according to Tenover et al. [10] and Molecular Analyst Fingerprinting (MAF, Bio-Rad).

Results

Seventeen K. pneumoniae (60.7%) strains were isolated from colonization. These strains were cultured from: throat swabs – 9 (32.2%), rectal swabs – 6 (21.4%) and stool samples – 2 (7.1%). Eleven (39.3%) strains were isolated from children with clinical symptoms of infection from: blood – 6 (21.4%), urine – 3 (10.8%) and cerebrospinal fluid samples – 2 (7.1%). All the K. pneumoniae strains in this study demonstrated ESBL-mediated resistance and most of them were resistant to ciprofloxacin. Among the analysed strains all of them were susceptible to imipenem, 21 (75.0%) to tigecycline, 14 (50.0%) to gentamicin and 5 (17.9%) to ciprofloxacin. Four K. pneumoniae strains were intermediate to tigecycline. The results of antimicrobial susceptibility testing are presented in Table I. Imipenem MICs were 0.19-1 mg/l. Tigecycline MICs varied from 0.25 mg/l to 8 mg/l. Gentamicin and ciprofloxacin MICs were 0.125-256 mg/l.
Table I

Antimicrobial susceptibility of K. pneumoniae ESBL-positive strains (n = 28)

AntibioticsSusceptibility patternNumber of strains
ImipenemGentamicinTigecyclineCiprofloxacin
SSSSa2
SRSSb2
SSRSc1
SSSRd9
SSRRe2
SRIRf4
SRSRg8

S – susceptible, I – intermediate, R – resistant

Antimicrobial susceptibility of K. pneumoniae ESBL-positive strains (n = 28) S – susceptible, I – intermediate, R – resistant Against the analysed K. pneumoniae strains, imipenem revealed the highest activity, with MIC50S 0.19 mg/l and MIC90S 0.38 mg/l. Against the analysed K. pneumoniae strains, ciprofloxacin showed the lowest activity, with MIC50S 2 mg/l and MIC90S 16 mg/l. According to the PFGE testing results, the study strains were divided into four subgroups: 7 (25.0%) identical strains (group A – lines 9, 10, 10*, 12, 12*, 13, 13*); 9 (32.2%) closely related strains (group B – lines 2, 8, 8*, 9*, 11, 11*, 14*, 16, 16*); 4 (14.2%) possibly related strains (group C – lines 1, 5, 7, 7*); and 8 (28.6%) unrelated strains (group D – lines 3, 4, 6, 14, 15, 15*, 17, 18). The results of PFGE and MAF are presented in Figures 1 and 2. Among K. pneumoniae strains, which were isolated from colonization, 3 identical, 5 closely related, 2 possibly related and 7 different strains were detected according to Tenover et al. [10]. Among K. pneumoniae strains which were cultured from infections, 4 identical, 4 closely related, 2 possibly related and 1 different strains were detected according to Tenover [10]. Six strains showed 95% similarity according to MAF.
Figure 1

PFGE fingerprinting of XbaI –digested DNA from K. pneumoniae ESBL-positive strains (n = 28)

M – Lamba Ladder stander, 1-16 strain number, strains marked *were isolated from infections

Figure 2

Dendrogram of the K. pneumoniae strains

PFGE fingerprinting of XbaI –digested DNA from K. pneumoniae ESBL-positive strains (n = 28) M – Lamba Ladder stander, 1-16 strain number, strains marked *were isolated from infections Dendrogram of the K. pneumoniae strains Among identical K. pneumoniae strains four susceptibility patterns were noted (b, d, e, g). All identical strains were susceptible to imipenem. Among closely related strains four susceptibility patterns (d, e, f, g) were detected. These strains were susceptible to imipenem and resistant to ciprofloxacin. Among possibly related strains two susceptibility patterns were detected (a, g). These strains were susceptible to imipenem and tigecycline. Among different K. pneumoniae strains three susceptibility patterns were detected (c, d, f). All of these strains were susceptible to imipenem. The K. pneumoniae strains that were isolated from the same child from colonization and infection had the same susceptibility pattern (Table II). Among the analysed strains “d” and “g” susceptibility patterns dominated. These patterns were detected in 9 (32.1%) and 8 (28.6%) strains, respectively. The K. pneumoniae strains cultured from the same child from colonization and infection belonged to the same genetic group in 8 cases.
Table II

Antimicrobial and genetic patterns of K. pneumoniae ESBL-positive strains (n = 15)

Strain numberGenetic patternSusceptibility patternData of isolationMIC value [mg/l]
ImipenemGentamicinTigecyclineCiprofloxacin
1DcX 20060.250.12540.125
2BfXII 20060.7581.564
3DfX 20060.1258264
7CaIX 20060.190.250.0470.125
7*CaX 20060.190.50.0470.5
8DdIX 20060.190.2512
8*DdIX 20061112
9AeIX 20060.75284
9*BeIX 20060.75284
10AbX 20060.193210.5
10*AbX 20060.196410.5
11BdIX 20060.1250.50.516
11*BdX 20060.12510.564
17DdX 20060.1920.58
18AdIX 20060.192116

Strains marked with the same numbers came from one child. Strains marked * were isolated from infections

Antimicrobial and genetic patterns of K. pneumoniae ESBL-positive strains (n = 15) Strains marked with the same numbers came from one child. Strains marked * were isolated from infections Antimicrobial and genetic patterns of K. pneumoniae ESBL-positive strains (n = 13) Strains marked with the same numbers came from one child. Strains marked were isolated from infections

Discussion

Klebsiella pneumoniae bacilli can be typed by means of various methods. The commonly applied typing methods rely on biochemical properties, phage typing, and serological typing or drug sensitivity profiles. These methods, however, do not always provide a proper interpretation of an epidemiological situation. Molecular biology methods, including PFGE, allow for genetic differentiation of strains belonging to the same species. They are not commonly used in laboratories due to the lack of equipment and insufficient staff training. The studies of Demirdag and Hosoglu [2], Dzierżanowska et al. [3] and Ktari et al. [11] prove the usefulness of both methods applied in this study for K. pneumoniae strain typing. Seven drug sensitivity profiles were determined among 28 K. pneumoniae strains in this study. On this basis it can be assumed that certain K. pneumoniae strains survive in the clinic environment in which colonised patients or patients infected with these bacilli stayed. Strain typing on the basis of the drug sensitivity profile was one of the most frequently used methods in hospital strains. The introduction of genetic methods provided new opportunities within their typing and similarity determination. The results of PFGE chromosomal DNA isolation obtained in the study prove that during 15 months genetically identical K. pneumoniae strains were isolated from different children, in the case of both colonisation and infection. This may prove maintenance of colonization and dissemination of strains in children treated in the clinic involved in the study. From the results it was deduced that strains classified in the same group on the grounds of chromosomal DNA patterns can have different drug sensitivity profiles. Similar results were obtained by Bagattini et al. [12] when studying K. pneumoniae ESBL-positive strains isolated from children treated in the neonatal intensive care unit. No direct correlation was found between PFGE profiles and antibiotic susceptibility patterns. Isolates with identical antibiotypes belonged to different PFGE types. The various drug sensitivity profiles obtained for genetically identical K. pneumoniae strains may result from development of plasmid-encoded resistance genes. Non-compliance of a sanitary regime in the department as well as patients’ migration within departments may affect development of drug sensitivity resistance genes through clinic strains. Equally significant is the ability of strains with different resistance mechanisms to survive in the hospital environment. Differences in MIC values for antibiotics of K. pneumoniae strains isolated from the same patient may suggest that survival of strains in a human body facilitates development of drug resistance during antibiotic therapy. In conclusion, the results of the study suggest that establishing strains’ similarity in epidemiological investigations should be based on results obtained by several methods, and that each phenotyping method should be complemented with genetic research.
Table III

Antimicrobial and genetic patterns of K. pneumoniae ESBL-positive strains (n = 13)

Strain numberGenetic patternSusceptibility patternData of isolationMIC value [mg/l]
ImipenemGentamicinTigecyclineCiprofloxacin
4DdX 20070.752132
5DdX 20070.380.1250.254
6AdX 20070.380.1250.54
12AgIX 20070.25160.752
12*BgX 20070.25320.752
13AgX 20070.1925614
13*AgX 20070.1925618
14CgXI 20071320.532
14*CgXI 200712561256
15DfXI 20070.1981.532
15*DfXI 20070.1916232
16BgXI 20070.125812
16*BgXI 20070.1251614

Strains marked with the same numbers came from one child. Strains marked

were isolated from infections

  11 in total

1.  Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum beta-lactamase, and CMY-4 AmpC beta-lactamase in a Tunisian university hospital.

Authors:  Sonia Ktari; Guillaume Arlet; Basma Mnif; Valérie Gautier; Fouzia Mahjoubi; Mounir Ben Jmeaa; Mounir Bouaziz; Adnane Hammami
Journal:  Antimicrob Agents Chemother       Date:  2006-10-02       Impact factor: 5.191

2.  Comparison of PFGE and multilocus sequence typing for analysis of Klebsiella pneumoniae isolates.

Authors:  Sophie Vimont; Basma Mnif; Cindy Fevre; Sylvain Brisse
Journal:  J Med Microbiol       Date:  2008-10       Impact factor: 2.472

3.  Clonal spread of CTX-M-15-producing Klebsiella pneumoniae in a Croatian hospital.

Authors:  Mirna Vranic-Ladavac; Zrinka Bosnjak; Natasa Beader; Nada Barisic; Smilja Kalenic; Branka Bedenic
Journal:  J Med Microbiol       Date:  2010-06-24       Impact factor: 2.472

Review 4.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

5.  Epidemiology and risk factors for ESBL-producing Klebsiella pneumoniae: a case control study.

Authors:  Kutbettin Demirdag; Salih Hosoglu
Journal:  J Infect Dev Ctries       Date:  2010-11-24       Impact factor: 0.968

6.  Extended Spectrum Beta-Lactamase-producing Klebsiella pneumoniae outbreaks during a third generation cephalosporin restriction policy.

Authors:  M P Conte; M Venditti; F Chiarini; G D'Ettorre; I Zamboni; G L Scoarughi; C Gallinelli; G B Orsi
Journal:  J Chemother       Date:  2005-02       Impact factor: 1.714

7.  Carriage of genes for various extended-spectrum beta-lactamases: a novel resistance strategy of Klebsiella pneumoniae in Poland.

Authors:  Danuta Dzierzanowska; Wanda Kamińska; Katarzyna Semczuk; Dariusz Borowiec; Michał Matysiak; Anna Szumała-Kakol; Rafał Gierczyński; Jan A Patzer
Journal:  Int J Antimicrob Agents       Date:  2010-04       Impact factor: 5.283

8.  Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals.

Authors:  Joanna Empel; Anna Baraniak; Elzbieta Literacka; Agnieszka Mrówka; Janusz Fiett; Ewa Sadowy; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

9.  Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit.

Authors:  Maria Bagattini; Valeria Crivaro; Anna Di Popolo; Fabrizio Gentile; Alda Scarcella; Maria Triassi; Paolo Villari; Raffaele Zarrilli
Journal:  J Antimicrob Chemother       Date:  2006-03-10       Impact factor: 5.790

10.  Molecular epidemiology of multidrug resistant extended spectrum beta-lactamase producing Klebsiella pneumoniae at a Jamaican hospital, 2000-2004.

Authors:  Nicole A Christian; Karen Roye-Green; Monica Smikle
Journal:  BMC Microbiol       Date:  2010-01-28       Impact factor: 3.605

View more
  4 in total

1.  Molecular typing of clinical and environmental isolates of Klebsiella pneumoniae producing ESBLs by PFGE.

Authors:  Mohammad Esmaeilnia; Mahmood Saffari; Somaye Rashki; Zeynab Marzhoseyni; Azad Khaledi; Gholam Abbas Moosavi; Fatemeh Atoof; Behrang Alani
Journal:  Iran J Basic Med Sci       Date:  2022-02       Impact factor: 2.532

2.  Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems.

Authors:  Joanna Matuszkiewicz-Rowińska; Jolanta Małyszko; Monika Wieliczko
Journal:  Arch Med Sci       Date:  2015-03-14       Impact factor: 3.318

3.  Admission prevalence of colonization with third-generation cephalosporin-resistant Enterobacteriaceae and subsequent infection rates in a German university hospital.

Authors:  Anne-Cathérine Boldt; Frank Schwab; Anna M Rohde; Axel Kola; Minh Trang Bui; Nayana Märtin; Marina Kipnis; Christin Schröder; Rasmus Leistner; Miriam Wiese-Posselt; Janine Zweigner; Petra Gastmeier; Luisa A Denkel
Journal:  PLoS One       Date:  2018-08-01       Impact factor: 3.240

4.  Nosocomial rotavirus gastroenterocolitis in a large tertiary paediatric hospital in Warsaw, 2006-2010.

Authors:  Aneta Nitsch-Osuch; Ernest Kuchar; Anna Kosmala; Katarzyna Zycinska; Kazimierz Wardyn
Journal:  Arch Med Sci       Date:  2013-02-10       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.